Global Veterinary Medicines Market | Trends, Analysis, Size

1
Animal Healthcare Spending to Stimulate the
Global Veterinary Medicines Market at CAGR of
4.11 by 2028
Triton Market Research presents the Global
Veterinary Medicines Market report segmented by
Route of Administration (Oral Route, Parenteral
Route, Topical Route), Animal Type (Livestock
Animals, Companion Animals), Product (Vaccines
Attenuated Vaccines, Inactivated Vaccines,
Recombinant Vaccines, Medicated Feed Additives
Amino Acids, Antibiotics, Drugs
Anti-Inflammatory, Parasiticide,
Anti-Infective), Distribution Channel
(Veterinary Hospital Pharmacies, Retail
Veterinary Pharmacies), and by Geography
(Asia-Pacific, North America, Middle East and
Africa, Latin America, Europe). The report
further discusses the Market Summary, Industry
Outlook, Market Definition, Porter's Five Forces
Model, Industry Components, Legal Policy and
Regulatory Framework, Impact of COVID-19, Market
Attractiveness Index, Key Insight, Drivers,
Restraints, Opportunities, Challenges, Company
Profiles, Research Methodology Scope, Global
Market Size, Forecasts Analysis (2019-2028).
Request a Free Sample https//www.tritonmarketres
earch.com/reports/veterinary-medicines-marketrequ
est-free-sample Triton's report infers that the
global veterinary medicines market is predicted
to witness growth by 4.11 of CAGR during the
considered years of 2019-2028. Veterinary
medicine can be defined as a drug that is
employed in the treatment of animals. These
medicines include various types of products, such
as anti-infective drugs to prevent, eradicate, or
slow the growth of multiple infection-causing
organisms. The rising animal healthcare
expenditure and surging demand for veterinary
specialization, are factors opening multiple
avenues for the growth of the veterinary
medicines market globally. The treatment of
animal diseases requires a substantial amount of
funds. In recent times, the number of pet owners
2
spending and seeking treatments for their pets
has grown, enhancing the need for veterinary
medicines. However, stringent regulations and
the high cost of animal vaccines are significant
challenges affecting the progression of
veterinary medicines. Geographically, North
America holds the largest market for veterinary
medicines, and is likely to continue dominating
the market till 2028. The region's growth is
mainly owing to the presence of several
prominent players. For instance, Zoetis Inc and
Merck Co are headquartered in the United
States, which has lead to the easy availability
of veterinary medicines in the region.
Additionally, several such key players have
implemented numerous strategies to sustain in the
market. This further adds to the growth of the
veterinary medicines market across North
America. The well-known companies present in the
veterinary medicines market include Ceva Sante
Animale, Archer Daniels Midland, Kindred
Biosciences, Boehringer Ingelheim Animal Health
GmbH, Hester Biosciences Limited, Indian
Immunologicals Limited, Elanco, Biogenesis Bago
SA, Neogen Corporation, Merck Co, Dechra
Pharmaceuticals Plc, Zoetis, Virbac SA, Evonik
Industries AG, and Vetoquinol. The threat of new
players in the veterinary medicines market is
likely to remain moderate over the estimated
period. The high operating costs and strict
regulations are major factors restricting the
entry of new players. On the other hand, the
competition among the existing players is
expected to be at a higher level. This is mainly
because the companies adopt extensive growth
strategies, such as entering into strategic
alliances, rising product differentiation, and
more. Contact Us sales_at_tritonmarketresearch.com
Phone [phone]